Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year net income growth rate
Percentile
P21
Within normal range
vs 5Y Ago
-8.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -14.50% |
| Q3 2025 | -5.51% |
| Q2 2025 | -37.86% |
| Q1 2025 | 70.88% |
| Q4 2024 | -17.24% |
| Q3 2024 | -0.43% |
| Q2 2024 | 1.18% |
| Q1 2024 | 30.73% |
| Q4 2023 | -12.28% |
| Q3 2023 | -14.37% |
| Q2 2023 | 21.57% |
| Q1 2023 | 42.80% |
| Q4 2022 | 41.18% |
| Q3 2022 | -15.19% |
| Q2 2022 | -1.19% |
| Q1 2022 | 4.19% |
| Q4 2021 | -45.07% |
| Q3 2021 | 87.35% |
| Q2 2021 | 19.98% |
| Q1 2021 | -0.57% |
| Q4 2020 | 1.78% |
| Q3 2020 | 64.81% |
| Q2 2020 | -8.73% |
| Q1 2020 | -6.48% |
| Q4 2019 | -22.56% |
| Q3 2019 | -0.60% |
| Q2 2019 | 26.09% |
| Q1 2019 | 25.86% |
| Q4 2018 | -36.26% |
| Q3 2018 | 38.21% |
| Q2 2018 | -25.81% |
| Q1 2018 | 36.53% |
| Q4 2017 | -11.68% |
| Q3 2017 | -13.42% |
| Q2 2017 | 6.64% |
| Q1 2017 | 70.19% |
| Q4 2016 | -11.99% |
| Q3 2016 | 37.32% |
| Q2 2016 | -48.86% |
| Q1 2016 | 193.74% |